Scott Pantel, Founder & CEO of LSI & Emerging Medtech Summit, sits down with Benjamin Glenn of A Matter of Innovation at #LSI2021 Life Science Intelligence to discuss his market intelligence company’s data driven commitment to curating the perfect mix of innovators, investors and strategics that are the future of healthcare, the practical process that leads to so many successful investments, keeping a finger on the pulse of industry trends, the current emphasis on digital surgery, back-to-back panels bringing together 170 innovators with a total of 400 exits (worth billions) with sincere, active investors; dispelling the myths about SPACs, powerful and insightful keynotes, beautiful dinners by the Pacific Ocean, prescient predictions, meeting the challenge of hosting a safe in-person event, and a big thank you to friends and supporters whose commitment to the industry continues to bring life saving technologies to the patients who need them. AMOI Website
Benjamin Glenn is nationally recognized innovation strategist, speaker and coach based in the Silicon Valley. His work is keenly focused on helping entrepreneurs and innovators in enterprises big and small in our regulated industries identify, develop and maintain competitive advantages. Particularly with regard to our rapidly evolving health care sector, Benjamin's work is highlighted in Biodesign: The Process of Innovating Medical Technologies, a program he has served for over a decade.
Benjamin strongly believes in the increasing importance, and even the necessity, of creating and training a while array of multi-disciplinary teams. Benjamin's passionate presentations often focus on how professionals from different disciplines can successfully work together to create the products and services of the modern economy.
In his presentations, Benjamin draws on his diverse experiences growing up in Texas, serving in the military and working as a Silicon Valley patent attorney. His unique, humorous and often metaphor-ladened insights also draw from over two decades of advising clients on strategic, commercial, innovation and product development issues. As a result, his engaging style has inspired and entertained audiences at leading innovation and entrepreneurial programs nationwide including:
Stanford University BioDesign Program, UC San Francisco, Johns Hopkins University and Northwestern University, along with accelerator and incubator programs such as Matter Chicago, Texas Medical Center’s TMCx, South By SouthWest, VentureWell, Village Capital, Kauffman Foundation, Singularity University, and MedTech Innovator.
Benjamin Glenn is nationally recognized innovation strategist, speaker and coach based in the Silicon Valley. His work is keenly focused on helping entrepreneurs and innovators in enterprises big and small in our regulated industries identify, develop and maintain competitive advantages. Particularly with regard to our rapidly evolving health care sector, Benjamin's work is highlighted in Biodesign: The Process of Innovating Medical Technologies, a program he has served for over a decade.
Benjamin strongly believes in the increasing importance, and even the necessity, of creating and training a while array of multi-disciplinary teams. Benjamin's passionate presentations often focus on how professionals from different disciplines can successfully work together to create the products and services of the modern economy.
In his presentations, Benjamin draws on his diverse experiences growing up in Texas, serving in the military and working as a Silicon Valley patent attorney. His unique, humorous and often metaphor-ladened insights also draw from over two decades of advising clients on strategic, commercial, innovation and product development issues. As a result, his engaging style has inspired and entertained audiences at leading innovation and entrepreneurial programs nationwide including:
Stanford University BioDesign Program, UC San Francisco, Johns Hopkins University and Northwestern University, along with accelerator and incubator programs such as Matter Chicago, Texas Medical Center’s TMCx, South By SouthWest, VentureWell, Village Capital, Kauffman Foundation, Singularity University, and MedTech Innovator.
CEO, Founder, and proud member and connector in the Medtech ecosystem. As CEO of LSI, a global healthcare market research and advisory firm, I support startups, investors, strategics, and professional service companies by providing independent market data/insights to help inform their decisions. I aim to leverage my deep network to connect investors with innovators tackling the world's biggest healthcare challenges. Proud to be the Founder of the US and European Emerging Medtech Summit events which have become the go-to investment & partnering conferences in Medtech. I've managed over 200 consulting and due diligence engagements with companies such as J&J, Medtronic, Abbott, Siemens Healthineers, General Electric, amongst others. Proud and honored to serve as a Board Advisor to several early/growth-stage companies and to advise private investors, family offices, PE firms, and SPACs to identify new opportunities in healthcare.
CEO, Founder, and proud member and connector in the Medtech ecosystem. As CEO of LSI, a global healthcare market research and advisory firm, I support startups, investors, strategics, and professional service companies by providing independent market data/insights to help inform their decisions. I aim to leverage my deep network to connect investors with innovators tackling the world's biggest healthcare challenges. Proud to be the Founder of the US and European Emerging Medtech Summit events which have become the go-to investment & partnering conferences in Medtech. I've managed over 200 consulting and due diligence engagements with companies such as J&J, Medtronic, Abbott, Siemens Healthineers, General Electric, amongst others. Proud and honored to serve as a Board Advisor to several early/growth-stage companies and to advise private investors, family offices, PE firms, and SPACs to identify new opportunities in healthcare.
Scott Pantel, Founder & CEO of LSI & Emerging Medtech Summit, sits down with Benjamin Glenn of A Matter of Innovation at #LSI2021 Life Science Intelligence to discuss his market intelligence company’s data driven commitment to curating the perfect mix of innovators, investors and strategics that are the future of healthcare, the practical process that leads to so many successful investments, keeping a finger on the pulse of industry trends, the current emphasis on digital surgery, back-to-back panels bringing together 170 innovators with a total of 400 exits (worth billions) with sincere, active investors; dispelling the myths about SPACs, powerful and insightful keynotes, beautiful dinners by the Pacific Ocean, prescient predictions, meeting the challenge of hosting a safe in-person event, and a big thank you to friends and supporters whose commitment to the industry continues to bring life saving technologies to the patients who need them. AMOI Website
Market Intelligence
Schedule an exploratory call
Request Info17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy